CD8A and neoplasm: The TGFb produced by regulatory B lymphocytes can convert regulatory CD4 T lymphocytes, which inhibit NK cells and effector CD8 T lymphocytes, blocking the induction of T lymphocyte-mediated tumor immunity and inactivating CD4 T lymphocytes22.